Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Arrhythmia).php on line 2
Heart (Arrhythmia)
LE WE PMID CA
Heart (Arrhythmia)219Herz (Arrhythmie)

Adenosine

Antiarrhythmic agents

Calsequestrin

Cocain

Fatty acids (Omega3)

Gap junction

Heart (Anatomy)

Heart (Arrhythmia)

Heart (Atrial fibrillation)

Heart (Body surface potential mapping)

Heart (Brugada s syndrome)

Heart (Cardiomyopathy BASKET)

Heart (Cardiomyopathy dilated)

Heart (Conduction system)

Heart (Coronary heart disease BASKET)

Heart (Electrocardiography)

Heart (Electrophysiological examination)

Heart (Holter EKG)

Heart (Inherited and congenital diseases in grown up patients)

Heart (Inherited and congenital diseases)

Heart (Sick sinus syndrome)

Heart (Ventricular fibrillation)

Heart failure (chronical)

Ion channel (BASKET)

Ion channel (Sodium)

Ischemia reperfusion

Long QT syndrome

Magnesium

Mitochondria (BASKET)

Pregnancy (Diseases)

Progressive cardiac conduction disease

RAAS (Local Heart)

Receptor (Ryanodine)

Remodeling

SCN5A

SERCA

SIDS cot death

Statin

Sudden death (cardiogenic)

Systemic lupus erythematosus

T wave alternans

Verapamil

2006  
1
Dysregulation of cell adhesion proteins and cardiac arrhythmogenesis.
[16595792] Clin Med Res 4(1): 42-52 (2006)
2008  
2
Heart-brain interactions in cardiac arrhythmias: role of the autonomic nervous system.
[18540155] Cleve Clin J Med 75 Suppl 2(): S94-6 (2008)
2008  
3
Initial management of cardiac arrhythmias.
[18592068] Aust Fam Physician 37(7): 516-20 (2008)
2007  
4
Emergency management of acute cardiac arrhythmias.
[17619662] Aust Fam Physician 36(7): 492-7 (2007)
1997  
5
Perioperative cardiac dysrhythmias: diagnosis and management.
[9197314] Anesthesiology 86(6): 1397-424 (1997)
1990  
6
Mechanisms for cardiac dysrhythmias during anesthesia.
[2405744] Anesthesiology 72(2): 347-74 (1990)
2005  
7
Genetics of cardiac arrhythmias.
[16162633] Heart 91(10): 1352-8 (2005)
1990  
8
Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias.
[2178658] Br Heart J 63(1): 3-4 (1990)
2010  
9
Sodium channel (dys)function and cardiac arrhythmias.
[20645984] Cardiovasc Ther 28(5): 287-94 (2010)
2008  
10
Role of potassium currents in cardiac arrhythmias.
[18653669] Europace 10(10): 1133-7 (2008)
2006  
11
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
[16935866] Europace 8(9): 746-837 (2006)
2005  
12
Of circles and spirals: bridging the gap between the leading circle and spiral wave concepts of cardiac reentry.
[16102499] Europace 7 Suppl 2(): 10-20 (2005)
2005  
13
Mechanisms of inherited cardiac conduction disease.
[15763526] Europace 7(2): 122-37 (2005)
2008  
14
Drug therapy considerations in arrhythmias in children.
[18679519] Indian Pacing Electrophysiol J 8(3): 202-10 (2008)
2008  
15
Difficulties with ablation for arrhythmias in children.
[18478062] Indian Pacing Electrophysiol J 8(Suppl. 1): S55-74 (2008)
2003  
16
Role of adenosine/ATP test in supraventricular tachycardia.
[16943984] Indian Pacing Electrophysiol J 3(1): 1-2 (2003)
2005  
17
2005  
18
The molecular genetics of arrhythmias.
[16005449] Cardiovasc Res 67(3): 343-6 (2005)
2005  
19
Susceptibility genes and modifiers for cardiac arrhythmias.
[15949790] Cardiovasc Res 67(3): 397-413 (2005)
2004  
20
Electrophysiological changes in heart failure and their relationship to arrhythmogenesis.
[14736537] Cardiovasc Res 61(2): 208-17 (2004)
2001  
21
New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias(1).
[11738052] Cardiovasc Res 52(3): 345-60 (2001)
2001  
22
Pharmacogenetics and drug-induced arrhythmias.
[11334826] Cardiovasc Res 50(2): 224-31 (2001)
2001  
23
Concealed arrhythmogenic syndromes: the hidden substrate of idiopathic ventricular fibrillation?
[11334825] Cardiovasc Res 50(2): 218-23 (2001)
1999  
24
Role of sympathoadrenergic mechanisms in arrhythmogenesis.
[10615409] Cardiovasc Res 43(4): 832-4 (1999)
1999  
25
Are the arrhythmias due to myocardial ischaemia and infarction dependent upon the sympathetic system?
[10615408] Cardiovasc Res 43(4): 830-1 (1999)
1999  
26
Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias.
[10533569] Cardiovasc Res 42(2): 309-17 (1999)
1998  
27
Damage-induced arrhythmias: reversal of excitation-contraction coupling.
[10070485] Cardiovasc Res 40(3): 444-55 (1998)
1998  
28
Role of cardiac chloride currents in changes in action potential characteristics and arrhythmias.
[9876314] Cardiovasc Res 40(1): 23-33 (1998)
1998  
29
Animal models of cardiac arrhythmias.
[9764198] Cardiovasc Res 39(1): 165-77 (1998)
1998  
30
The membrane current (I(f)) in human atrial cells: implications for atrial arrhythmias.
[9747423] Cardiovasc Res 38(3): 537-40 (1998)
1996  
31
Mahaim, Kent and abnormal atrioventricular conduction.
[8689639] Cardiovasc Res 31(4): 480-91 (1996)
1986  
32
1978  
33
The electrocardiogram in the assessment of the effect of drugs on cardiac arrhythmias.
[365208] Br J Clin Pharmacol 6(6): 473-85 (1978)
2005  
34
Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias.
[16038623] Acta Pharmacol Sin 26(8): 918-25 (2005)
2006  
35
Pathophysiological mechanism of cardiac arrhythmias as a key for optimal nonpharmacological treatment.
[17244939] J Physiol Pharmacol 57 Suppl 11(): 69-77 (2006)
1997  
36
Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action.
[9082021] J Nutr 127(3): 383-93 (1997)
2008  
37
Molecular mechanisms of inherited arrhythmias.
[19440513] Curr Genomics 9(3): 160-8 (2008)
1989  
38
Results of direct surgical ablation of ventricular tachycardia not due to ischemic heart disease.
[2658882] Ann Surg 209(6): 716-27 (1989)
2007  
39
Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes.
[17586620] Am J Physiol Heart Circ Physiol 293(4): H2024-38 (2007)
2006  
40
In vivo dispersion in repolarization and arrhythmias in the human heart.
[16373596] Am J Physiol Heart Circ Physiol 290(1): H77-8 (2006)
2004  
41
Somatic gene and cell therapy strategies for the treatment of cardiac arrhythmias.
[14766670] Am J Physiol Heart Circ Physiol 286(3): H815-22 (2004)
1994  
42
Radiofrequency catheter ablation for cardiac tachyarrhythmias.
[8053620] Ann Intern Med 121(6): 452-61 (1994)
2005  
43
Understanding cardiac arrhythmias.
[16177167] Arch Dis Child 90(10): 1086-90 (2005)
1985  
44
The technique of catheter ablation of cardiac arrhythmias.
[4053706] Chest 88(5): 647-8 (1985)
1985  
45
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
[3930162] Chest 88(4): 618-24 (1985)
2008  
46
The left ventricular ostium: an anatomic concept relevant to idiopathic ventricular arrhythmias.
[19808434] Circ Arrhythm Electrophysiol 1(5): 396-404 (2008)
2003  
47
Recent advances in the treatment of arrhythmias.
[12890903] Circ J 67(8): 651-5 (2003)
2003  
48
A surprising new arrhythmia mechanism in heart failure.
[14525920] Circ Res 93(7): 589-91 (2003)
2003  
49
Antiarrhythmic drug target choices and screening.
[14500332] Circ Res 93(6): 491-9 (2003)
1984  
50
Antiarrhythmic drug action. Blockade of the inward sodium current.
[6090034] Circ Res 55(4): 427-39 (1984)
1981  
51
Cellular mechanisms for cardiac arrhythmias.
[7016362] Circ Res 49(1): 1-15 (1981)
1977  
52
Action potentials, afterpotentials, and arrhythmias.
[409566] Circ Res 41(4): 415-23 (1977)
1973  
53
Mechanisms of action of antiarrhythmic drugs.
[4567446] Circ Res 32(1): 1-8 (1973)
2008  
54
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
[18483207] Circulation 117(21): e350-408 (2008)
2007  
55
Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function.
[17998470] Circulation 116(20): 2325-45 (2007)
2005  
56
Molecular basis of arrhythmias.
[16230503] Circulation 112(16): 2517-29 (2005)
2003  
57
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias).
[14557344] Circulation 108(15): 1871-909 (2003)
2001  
58
New approaches to antiarrhythmic therapy, Part I: emerging therapeutic applications of the cell biology of cardiac arrhythmias.
[11733408] Circulation 104(23): 2865-73 (2001)
1999  
59
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III.
[9950666] Circulation 99(5): 674-81 (1999)
1999  
60
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II.
[9927398] Circulation 99(4): 518-28 (1999)
2001  
61
New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias.
[11913477] Eur Heart J 22(23): 2148-63 (2001)
2001  
62
Immunological basis of the cardiac conduction and rhythm disorders.
[11350091] Eur Heart J 22(10): 813-24 (2001)
1999  
63
Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiology.
[10082151] Eur Heart J 20(3): 174-95 (1999)
1998  
64
The search for novel antiarrhythmic strategies. Sicilian Gambit.
[9740340] Eur Heart J 19(8): 1178-96 (1998)
1997  
65
Dispersion of repolarization. A basic electrophysiological mechanism behind malignant arrhythmias.
[9458407] Eur Heart J 18(8): 1200-2 (1997)
1997  
66
Abnormal dynamics of ventricular repolarization--a new insight into the mechanisms of life-threatening ventricular arrhythmias.
[9183577] Eur Heart J 18(6): 893-5 (1997)
1996  
67
Non-pharmacological treatment of supraventricular arrhythmias.
[8809536] Eur Heart J 17 Suppl C(-): 26-34 (1996)
2002  
68
Patients with ventricular arrhythmias: who should be referred to an electrophysiologist?
[12381654] Heart 88(5): 544-50 (2002)
2001  
69
Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study.
[11454850] Heart 86(2): 219-20 (2001)
2001  
70
Radiofrequency catheter ablation of supraventricular arrhythmias.
[11303019] Heart 85(5): 594-600 (2001)
2000  
71
Antiarrhythmic drugs: from mechanisms to clinical practice.
[10956304] Heart 84(3): 339-46 (2000)
2000  
72
Antiarrhythmics--from cell to clinic: past, present, and future.
[10862579] Heart 84(1): 14-24 (2000)
1992  
73
Modulation of potassium channels by antiarrhythmic and antihypertensive drugs.
[1548049] Hypertension 19(3): 228-36 (1992)
1999  
74
Management of ventricular arrhythmias: detection, drugs, and devices.
[9917122] JAMA 281(2): 172-9 (1999)
2006  
75
Modern management of arrhythmias.
[16461474] Postgrad Med J 82(964): 117-25 (2006)
1985  
76
Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.
[3898053] Postgrad Med J 61(718): 665-77 (1985)
1999  
77
Ventricular arrhythmias in congestive heart failure: clinical significance and management.
[10217470] Tex Heart Inst J 26(1): 42-59 (1999)
1984  
78
Recent trends in the management of life-threatening ventricular arrhythmias.
[6516336] West J Med 141(5): 649-65 (1984)
1977  
79
Medical staff conference. The significance and treatment of long-term ventricular arrhythmias.
[613537] West J Med 126(3): 209-14 (1977)
2004  
80
Cardiac arrhythmias: the quest for a cure: a historical perspective.
[15364313] J Am Coll Cardiol 44(6): 1155-63 (2004)
2003  
81
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society.
[14563598] J Am Coll Cardiol 42(8): 1493-531 (2003)
1988  
82
2010  
83
A sympathetic model of L-type Ca2+ channel-triggered arrhythmias.
[19897704] Am J Physiol Heart Circ Physiol 298(1): H3-4 (2010)
2007  
84
Mechanisms of human arrhythmia syndromes: abnormal cardiac macromolecular interactions.
[17928548] Physiology (Bethesda) 22(-): 342-50 (2007)
2010  
85
2007  
86
Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop.
[17768297] Circulation 116(10): e320-35 (2007)
2005  
87
Protecting the heart against arrhythmias: potassium current physiology and repolarization reserve.
[16145010] Circulation 112(10): 1376-8 (2005)
2008  
88
Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias.
[18391123] Circulation 117(14): 1890-3 (2008)
2009  
89
From the ryanodine receptor to cardiac arrhythmias.
[19667488] Circ J 73(9): 1561-7 (2009)
2010  
90
Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.
[20724725] Circ Res 107(4): 457-65 (2010)
2002  
91
Calcium and cardiac rhythms: physiological and pathophysiological.
[11786512] Circ Res 90(1): 14-7 (2002)
2004  
92
Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis.
[15094352] Cardiovasc Res 62(2): 323-34 (2004)
2007  
93
Do statins have an antiarrhythmic activity?
[17383620] Cardiovasc Res 75(1): 10-20 (2007)
2009  
94
Phosphoinositide signalling and cardiac arrhythmias.
[18940816] Cardiovasc Res 82(2): 286-95 (2009)
2008  
95
The sarcoplasmic reticulum and arrhythmogenic calcium release.
[18006483] Cardiovasc Res 77(2): 285-92 (2008)
2007  
96
Detection and reporting of drug-induced proarrhythmias: room for improvement.
[17766321] Europace 9 Suppl 4(-): iv23-36 (2007)
2009  
97
From mitochondrial dynamics to arrhythmias.
[19703656] Int J Biochem Cell Biol 41(10): 1940-8 (2009)
2011  
98
Inherited cardiac arrhythmias: diagnosis, treatment, and prevention.
[21977220] Dtsch Arztebl Int 108(37): 623-33; quiz 634 (2011)
2005  
99
Approaching cardiac arrhythmias in the elderly patient.
[16614646] MedGenMed 7(4): 24 (2005)
2006  
100
Arrhythmias in the elderly: modern management.
[16752528] Hellenic J Cardiol 47(2): 84-92 (2006)
2010  
101
Genetic testing for inherited cardiac arrhythmias.
[20378510] Hellenic J Cardiol 51(2): 92-103 (2010)
2009  
102
Cardiovascular translational medicine (IV): The genetic basis of malignant arrhythmias and cardiomyopathies.
[19401127] Rev Esp Cardiol 62(4): 422-36 (2009)
2004  
103
Perioperative cardiac arrhythmias.
[15145821] Br J Anaesth 93(1): 86-94 (2004)
2010  
104
Experimental models of spontaneous ventricular arrhythmias and of sudden cardiac death.
[20626217] Physiol Res 59 Suppl 1(-): S25-31 (2010)
2009  
105
Ryanodine receptor-mediated arrhythmias and sudden cardiac death.
[19345240] Pharmacol Ther 123(2): 151-77 (2009)
2010  
106
Cardiac neural remodeling and its role in arrhythmogenesis.
[20478404] Heart Rhythm 7(10): 1512-3 (2010)
2008  
107
Mechanistic insights into ventricular arrhythmias from mapping studies in humans.
[18456203] Heart Rhythm 5(6 Suppl): S53-8 (2008)
2008  
108
The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias.
[18456194] Heart Rhythm 5(6 Suppl): S12-7 (2008)
2008  
109
Cardiac fibrillation: from ion channels to rotors in the human heart.
[18468960] Heart Rhythm 5(6): 872-9 (2008)
2007  
110
Clinical use of body surface potential mapping in cardiac arrhythmias.
[17584668] Anadolu Kardiyol Derg 7 Suppl 1(-): 8-10 (2007)
2007  
111
SERCA in genesis of arrhythmias: what we already know and what is new?
[17584678] Anadolu Kardiyol Derg 7 Suppl 1(-): 43-6 (2007)
2010  
112
Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.
[20670193] Expert Rev Cardiovasc Ther 8(8): 1161-73 (2010)
2011  
113
Effective antioxidant therapy for the management of arrhythmia.
[21809958] Expert Rev Cardiovasc Ther 9(7): 797-800 (2011)
2010  
114
Cardiac sodium channelopathies.
[20091048] Pflugers Arch 460(2): 223-37 (2010)
2010  
115
A "rough" journey to the sarcoplasmic reticulum--implications of altered calsequestrin trafficking for cardiac arrhythmia.
[20603128] J Mol Cell Cardiol 49(4): 554-5 (2010)
2010  
116
Electrophysiological remodeling in heart failure.
[20096285] J Mol Cell Cardiol 48(4): 619-32 (2010)
2004  
117
Nature, significance, and mechanisms of electrical heterogeneities in ventricle.
[15368342] Anat Rec A Discov Mol Cell Evol Biol 280(2): 1010-7 (2004)
2010  
118
Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias.
[20573078] Br J Clin Pharmacol 69(5): 427-42 (2010)
2010  
119
Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside.
[20573080] Br J Clin Pharmacol 69(5): 448-57 (2010)
2006  
120
Best evidence topic report. Intravenous magnesium in shock-resistant tachyarrhythmias.
[16498164] Emerg Med J 23(3): 220-1 (2006)
2007  
121
Managing palpitations and arrhythmias during pregnancy.
[18003696] Heart 93(12): 1630-6 (2007)
2010  
122
Emergency diagnosis and management of pediatric arrhythmias.
[20930969] J Emerg Trauma Shock 3(3): 251-60 (2010)
2009  
123
The modulated dispersion hypothesis confirmed in humans.
[19808452] Circ Arrhythm Electrophysiol 2(2): 100-1 (2009)
2009  
124
2009  
125
2009  
126
Impact of dietary fatty acids on cardiac arrhythmogenesis.
[19808503] Circ Arrhythm Electrophysiol 2(4): 460-9 (2009)
2009  
127
New pharmacological agents for arrhythmias.
[19843928] Circ Arrhythm Electrophysiol 2(5): 588-97 (2009)
2005  
128
Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.
[15892662] Curr Pharm Des 11(12): 1561-72 (2005)
2010  
129
Efficacy of diagnostic tools for detecting cardiac arrhythmias: systematic literature search.
[21113379] Neth Heart J 18(11): 543-51 (2010)
2011  
130
Electrolyte disorders and arrhythmogenesis.
[21660912] Cardiol J 18(3): 233-45 (2011)
2009  
131
2008  
132
T-wave alternans testing for ventricular arrhythmias.
[18774011] Prog Cardiovasc Dis 51(2): 118-27 (2008)
2010  
133
Arrhythmias in systemic lupus erythematosus.
[21125143] Rev Bras Reumatol 50(1): 81-9 (2010)
2008  
134
Clinical use of and future perspectives on antiarrhythmic drugs.
[18762931] Eur J Clin Pharmacol 64(12): 1139-46 (2008)
2011  
135
Prediction of life-threatening arrhythmias--still an unresolved problem.
[21555886] Cardiology 118(2): 129-37 (2011)
2010  
136
T-wave alternans and arrhythmogenesis in cardiac diseases.
[21286254] Front Physiol 1(-): 154 (2010)
PMC   
137
Multiple accessory pathways in the young: the impact of structural heart disease.
[23237138] Am Heart J 165(1):87-92 (2013)
PMC   
138
NCX is an important determinant for premature ventricular activity in a drug-induced model of Andersen-Tawil syndrome.
[21697145] Cardiovasc Res 92(1):57-66 (2011)
PMC   
139
Drug-induced arrhythmia: pharmacogenomic prescribing?
[23091201] Eur Heart J 34(2):89-95 (2013)
PMC   
140
Tachy-brady arrhythmias: the critical role of adenosine-induced sinoatrial conduction block in post-tachycardia pauses.
[22985657] Heart Rhythm 10(1):110-8 (2013)
PMC   
141
Carvedilol analogue inhibits triggered activities evoked by both early and delayed afterdepolarizations.
[22982970] Heart Rhythm 10(1):101-7 (2013)
PMC   
142
Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart.
[24356527] J Am Heart Assoc 2(6):e000246 (2013)
PMC   
143
Attraction and repulsion of spiral waves by inhomogeneity of conduction anisotropy--a model of spiral wave interaction with electrical remodeling of heart tissue.
[23860834] J Biol Phys 39(1):67-80 (2013)
PMC   
144
Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome.
[22787014] Circ Arrhythm Electrophysiol 5(4):782-8 (2012)
PMC   
145
Bile acids induce arrhythmias: old metabolite, new tricks.
[23969477] Heart 99(22):1629-30 (2013)
PMC   
146
Spontaneous, pro-arrhythmic calcium signals disrupt electrical pacing in mouse pulmonary vein sleeve cells.
[24586364] PLoS One 9(2):e88649 (2014)
PMC   
147
Designer gap junctions that prevent cardiac arrhythmias.
[23245912] Trends Cardiovasc Med 23(2):33-8 (2013)
PMC   
148
Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes.
[24522951] Neth Heart J 22(4):160-6 (2014)
PMC   
149
Diagnostic Dilemmas for Underlying Pathophysiology of Arrhythmias Originating from the Right Ventricle.
[24669110] Indian Pacing Electrophysiol J 14(2):99-100 (2014)
PMC   
150
New insights into the management of rhythm and conduction disorders after acute myocardial infarction.
[24782917] Am J Case Rep 15():159-62 (2014)
PMC   
151
Post-myocardial infarction arrhythmia risk stratification using microvolt T-wave alternans.
[24778843] Curr Health Sci J 38(2):65-8 (2012)
PMC   
152
Xin Scaffolding Proteins and Arrhythmias.
[24734257] J Cardiol Clin Res 1(2):1011 (2013)
PMC   
153
Unpinning of rotating spiral waves in cardiac tissues by circularly polarized electric fields.
[24777360] Sci Rep 4():4831 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Arrhythmia).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Arrhythmia).php on line 92